The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $48.09

Today's change+0.36 +0.75%
Updated February 22 4:02 PM EST. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $48.09

Today's change+0.36 +0.75%
Updated February 22 4:02 PM EST. Delayed by at least 15 minutes.

NU Skin Enterprises Inc up (U.S.)$0.36

NU Skin Enterprises Inc closed up Wednesday by (U.S.)$0.36 or 0.75% to (U.S.)$48.09. Shares have lost 12.56% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 46.05% during the last year.

Key company metrics

  • Open(U.S.) $48.00
  • Previous close(U.S.) $47.73
  • High(U.S.) $49.20
  • Low(U.S.) $48.00
  • Bid / Ask-- / --
  • YTD % change+0.65%
  • Volume817,798
  • Average volume (10-day)917,547
  • Average volume (1-month)546,439
  • Average volume (3-month)696,735
  • 52-week range(U.S.) $27.74 to (U.S.) $66.04
  • Beta1.55
  • Trailing P/E19.06×
  • P/E 1 year forward15.27×
  • Forward PEG1.66×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield2.99%
  • Trailing EPS(U.S.) $2.52
Updated February 22 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.48%

Based on its net profit margin of 6.48%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.58%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue531604600472
Total other revenue--------
Total revenue531604600472
Gross profit423478472334
Total cost of revenue109126128138
Total operating expense471522521464
Selling / general / administrative362396392326
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income6182808
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax6277695
Income after tax3857453
Income tax, total2420242
Net income3857453
Total adjustments to net income--------
Net income before extra. items3857453
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3857453
Inc. avail. to common incl. extra. items3857453
Diluted net income3857453
Dilution adjustment--------
Diluted weighted average shares56585656
Diluted EPS excluding extraordinary itemsvalue per share0.690.980.790.06
Dividends per sharevalue per share0.360.360.360.36
Diluted normalized EPSvalue per share0.690.980.790.06